Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

The summary for the Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional): This Notice of Funding Opportunity (NOFO) solicits applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on sustaining operations and maintaining and evolving the scientific relevance of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that will be supported by companion ITCR NOFOs. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the application must provide clear justification for why the research resource should be maintained and how it has benefited and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting close engagement between the resource and the targeted research community should be described.This NOFO invites applications to support the sustained operations of informatics technology resources that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on sustaining resources that have had a demonstrated impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Evidence that the technology has had significant impact on cancer research to date and the sustainment plan will lead to the continued advancement of cancer researchRobust plans for supporting the end-user community including documentation, training, and other outreach activitiesClear processes for engaging end users to address emerging needs of the targeted research communities to ensure that the research resource maintains relevance to the research it supports
Federal Grant Title: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-27-021
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.393, 93.394, 93.395, 93.396, 93.399
CFDA Descriptions: Information not provided
Current Application Deadline: October 19th, 2026
Original Application Deadline: October 19th, 2026
Posted Date: May 21st, 2026
Creation Date: May 21st, 2026
Archive Date: December 19th, 2026
Total Program Funding: $1,800,000
Maximum Federal Grant Award: $600,000
Minimum Federal Grant Award: $50,000
Expected Number of Awards: 2
Cost Sharing or Matching: No
Last Updated: May 21st, 2026
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact
Center for Strategic Scientific Initiatives (CSSI)
[email protected]
[email protected]
Similar Government Grants
• Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
• Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
• Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinica...
• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 C...
• Pilot Studies in Pancreatic Cancer
• Cancer Prevention Research Small Grant Program
• Molecular Targets for Nutrients in Prostate Cancer Prevention
More Grants from the National Institutes of Health
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...
• Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
• NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
• Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com